Linda F. Carson

7.0k total citations · 1 hit paper
122 papers, 5.4k citations indexed

About

Linda F. Carson is a scholar working on Surgery, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Linda F. Carson has authored 122 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Surgery, 46 papers in Obstetrics and Gynecology and 40 papers in Reproductive Medicine. Recurrent topics in Linda F. Carson's work include Endometrial and Cervical Cancer Treatments (38 papers), Ovarian cancer diagnosis and treatment (37 papers) and Intraperitoneal and Appendiceal Malignancies (15 papers). Linda F. Carson is often cited by papers focused on Endometrial and Cervical Cancer Treatments (38 papers), Ovarian cancer diagnosis and treatment (37 papers) and Intraperitoneal and Appendiceal Malignancies (15 papers). Linda F. Carson collaborates with scholars based in United States, Canada and Australia. Linda F. Carson's co-authors include Leo B. Twiggs, Jeffrey M. Fowler, Sundaram Ramakrishnan, Maurie Markman, Levi S. Downs, Brian N. Bundy, Scott Wadler, David S. Alberts, Joshua Z. Sickel and Peter A. Argenta and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Linda F. Carson

120 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group

2001 792 citations Jeffrey M. Fowler, Linda F. Carson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linda F. Carson United States	39	2.3k	1.6k	1.5k	1.4k	1.0k	122	5.4k
Mark A. Morgan United States	45	1.8k 0.8×	1.7k 1.1×	2.2k 1.5×	1.4k 1.0×	1.1k 1.1×	201	6.8k
Rebecca N. Baergen United States	40	3.1k 1.4×	2.4k 1.5×	3.2k 2.2×	1.4k 1.0×	1.0k 1.0×	126	8.1k
Curt W. Burger Netherlands	47	2.4k 1.1×	1.2k 0.8×	1.3k 0.9×	838 0.6×	938 0.9×	162	6.0k
Gavin Stuart Canada	36	3.7k 1.6×	2.6k 1.6×	2.1k 1.5×	1.6k 1.1×	642 0.6×	118	6.1k
Creighton L. Edwards United States	35	1.6k 0.7×	1.2k 0.7×	1.3k 0.9×	1.0k 0.7×	707 0.7×	124	4.0k
Patricia L. Judson United States	25	1.4k 0.6×	850 0.5×	904 0.6×	1.2k 0.8×	598 0.6×	68	3.4k
Robert Giuntoli United States	38	2.0k 0.9×	1.0k 0.6×	1.8k 1.2×	793 0.6×	542 0.5×	168	4.0k
Walter H. Gotlieb Canada	42	2.5k 1.1×	1.1k 0.7×	2.3k 1.5×	1.6k 1.1×	1.7k 1.7×	244	6.4k
Bobbie S. Gostout United States	40	2.8k 1.2×	1.2k 0.8×	2.9k 1.9×	887 0.6×	1.0k 1.0×	92	6.6k
Gary L. Goldberg United States	38	1.1k 0.5×	1.0k 0.6×	1.4k 0.9×	1.2k 0.9×	723 0.7×	211	4.3k

Countries citing papers authored by Linda F. Carson

Since Specialization

Citations

This map shows the geographic impact of Linda F. Carson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda F. Carson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda F. Carson more than expected).

Fields of papers citing papers by Linda F. Carson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda F. Carson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda F. Carson. The network helps show where Linda F. Carson may publish in the future.

Co-authorship network of co-authors of Linda F. Carson

This figure shows the co-authorship network connecting the top 25 collaborators of Linda F. Carson. A scholar is included among the top collaborators of Linda F. Carson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda F. Carson. Linda F. Carson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dickson, Elizabeth L., Melissa A. Geller, Rachel I. Vogel, et al.. (2017). Enhanced Recovery Program and Length of Stay After Laparotomy on a Gynecologic Oncology Service. Obstetrics and Gynecology. 129(2). 355–362. 43 indexed citations

Hutchins, Jacob, Daniel J. Delaney, Rachel I. Vogel, et al.. (2015). Ultrasound guided subcostal transversus abdominis plane (TAP) infiltration with liposomal bupivacaine for patients undergoing robotic assisted hysterectomy: A prospective randomized controlled study. Gynecologic Oncology. 138(3). 609–613. 93 indexed citations

Argenta, Peter A., Thanasak Sueblinvong, Melissa A. Geller, et al.. (2013). Hyperthermic intraperitoneal chemotherapy with carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian carcinoma: A pilot study. Gynecologic Oncology. 129(1). 81–85. 25 indexed citations

Geller, Melissa A., Joseph J. Ivy, Rahel Ghebre, et al.. (2011). A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a “Sandwich” method for stage III, IV, and recurrent endometrial cancer. Gynecologic Oncology. 121(1). 112–117. 46 indexed citations

Chura, Justin, et al.. (2007). Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer☆. Gynecologic Oncology. 107(2). 326–330. 67 indexed citations

Downs, Levi S., Patricia L. Judson, Peter A. Argenta, Linda F. Carson, & Matthew Boente. (2004). A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer. Gynecologic Oncology. 95(2). 347–351. 4 indexed citations

Bradley, William H., Matthew Boente, Doris Brooker, et al.. (2004). Hysteroscopy and Cytology in Endometrial Cancer. Obstetrics and Gynecology. 104(5, Part 1). 1030–1033. 45 indexed citations

Judson, Patricia L., Amy L. Jonson, Pamela J. Paley, et al.. (2004). A prospective, randomized study analyzing sartorius transposition following inguinal–femoral lymphadenectomy. Gynecologic Oncology. 95(1). 226–230. 59 indexed citations

Geller, Melissa A., Peter A. Argenta, William H. Bradley, et al.. (2004). Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecologic Oncology. 95(3). 632–636. 47 indexed citations

10.

Paley, Pamela J., Peter R. Johnson, Leon L. Adcock, et al.. (1997). The Effect of Sartorius Transposition on Wound Morbidity Following Inguinal–Femoral Lymphadenectomy. Gynecologic Oncology. 64(2). 237–241. 40 indexed citations

11.

Carter, Jonathan, Jeffrey M. Fowler, Jay W. Carlson, et al.. (1995). The Utility of Preoperative Screening Colonoscopy in Gynecologic Oncology. Gynecologic Oncology. 56(2). 181–186. 4 indexed citations

12.

Singleton, Timothy P., Theresa Perrone, Gerard J. Oakley, et al.. (1994). Activation of c-erbB-2 and prognosis in ovarian carcinoma. Comparison with histologic type, grade, and stage. Cancer. 73(5). 1460–1466. 44 indexed citations

13.

Carter, Jonathan, Ellen M. Hartenbach, Jeffrey M. Fowler, et al.. (1994). Gray scale and color flow Doppler characterization of uterine tumors.. Journal of Ultrasound in Medicine. 13(11). 835–840. 8 indexed citations

14.

Fowler, Jeffrey M., et al.. (1993). Lymph Node Yield from Laparoscopic Lymphadenectomy in Cervical Cancer: A Comparative Study. Gynecologic Oncology. 51(2). 187–192. 75 indexed citations

15.

Carter, Jonathan, et al.. (1993). Transvaginal color flow Doppler sonography in the assessment of gestational trophoblastic disease. Journal of Ultrasound in Medicine. 12(10). 595–599. 17 indexed citations

16.

Carter, Jonathan, Theresa Perrone, Linda F. Carson, Jay W. Carlson, & Leo B. Twiggs. (1993). Uterine malignancy predicted by transvaginal sonography and color flow Doppler ultrasonography. Journal of Clinical Ultrasound. 21(6). 405–408. 4 indexed citations

17.

Carter, Jonathan, et al.. (1992). Transvaginal sonography as an aid in the clinical staging of carcinoma of the cervix. Journal of Clinical Ultrasound. 20(4). 283–287. 17 indexed citations

18.

King, Laurel A., Toru Tase, Leo B. Twiggs, et al.. (1989). Prognostic significance of the presence of human papillomavirus DNA in patients with invasive carcinoma of the cervix. Cancer. 63(5). 897–900. 63 indexed citations

19.

Twiggs, Leo B., et al.. (1989). Prognostic significance of steroid receptors measured in primary metastatic and recurrent endometrial carcinoma. American Journal of Obstetrics and Gynecology. 161(5). 1253–1257. 9 indexed citations

20.

Torday, John S., Linda F. Carson, & Edward E. Lawson. (1980). Saturated Phosphatidylcholine in Amniotic Fluid and Prediction of the Respiratory Distress Syndrome. Obstetrical & Gynecological Survey. 35(5). 276–276. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact